OBJECTIVES: To measure the prevalence of reproductive tract infections (RTIs) during pregnancy in Entebbe, Uganda, and to evaluate the current syndromic diagnosis and management approach in effectively targeting infections, such as bacterial vaginosis (BV) and trichomoniasis, that are associated with low birth weight and prematurity among newborns. METHODS: We enrolled 250 antenatal clinic attenders. Vaginal swabs and diagnostic tests were performed for BV, Trichomonas vaginalis (TV), candida, Neisseria gonorrhoeae, Chlamydia trachomatis and for HIV-1 and active (TPHA+/RPR+) syphilis infection. Same day treatment was offered for symptoms according to syndromic management guidelines. The treatment actually provided by healthcare workers was documented. Sensitivity, specificity, positive and negative predictive values were used to assess the effectiveness of syndromic management guidelines and practice. RESULTS: The prevalence of infections were: BV 47.7%, TV 17.3%, candida 60.6%, gonorrhoea 4.3%, chlamydia 5.9%, syphilis 1.6%, and HIV 13.1%. In total, 39.7% of women with BV and 30.2% of those with TV were asymptomatic. The sensitivity of syndromic management as applied by health workers in targeting BV and TV was 50.0% and 66.7%, respectively. This would have increased to 60.3% (BV) and 69.8% (TV) had the algorithm been followed exactly. CONCLUSIONS: The prevalence of BV and TV seen in this and other African populations is high. High rates of asymptomatic infection and a tendency of healthcare workers to deviate from management guidelines by following their own personal clinical judgment imply that many vaginal infections remain untreated. Alternative strategies, such as presumptive treatment of BV and TV in pregnancy, should be considered.
OBJECTIVES: To measure the prevalence of reproductive tract infections (RTIs) during pregnancy in Entebbe, Uganda, and to evaluate the current syndromic diagnosis and management approach in effectively targeting infections, such as bacterial vaginosis (BV) and trichomoniasis, that are associated with low birth weight and prematurity among newborns. METHODS: We enrolled 250 antenatal clinic attenders. Vaginal swabs and diagnostic tests were performed for BV, Trichomonas vaginalis (TV), candida, Neisseria gonorrhoeae, Chlamydia trachomatis and for HIV-1 and active (TPHA+/RPR+) syphilis infection. Same day treatment was offered for symptoms according to syndromic management guidelines. The treatment actually provided by healthcare workers was documented. Sensitivity, specificity, positive and negative predictive values were used to assess the effectiveness of syndromic management guidelines and practice. RESULTS: The prevalence of infections were: BV 47.7%, TV 17.3%, candida 60.6%, gonorrhoea 4.3%, chlamydia 5.9%, syphilis 1.6%, and HIV 13.1%. In total, 39.7% of women with BV and 30.2% of those with TV were asymptomatic. The sensitivity of syndromic management as applied by health workers in targeting BV and TV was 50.0% and 66.7%, respectively. This would have increased to 60.3% (BV) and 69.8% (TV) had the algorithm been followed exactly. CONCLUSIONS: The prevalence of BV and TV seen in this and other African populations is high. High rates of asymptomatic infection and a tendency of healthcare workers to deviate from management guidelines by following their own personal clinical judgment imply that many vaginal infections remain untreated. Alternative strategies, such as presumptive treatment of BV and TV in pregnancy, should be considered.
Authors: F Wabwire-Mangen; R H Gray; F A Mmiro; C Ndugwa; C Abramowsky; H Wabinga; C Whalen; C Li; A J Saah Journal: J Acquir Immune Defic Syndr Date: 1999-12-01 Impact factor: 3.731
Authors: R H Gray; F Wabwire-Mangen; G Kigozi; N K Sewankambo; D Serwadda; L H Moulton; T C Quinn; K L O'Brien; M Meehan; C Abramowsky; M Robb; M J Wawer Journal: Am J Obstet Gynecol Date: 2001-11 Impact factor: 8.661
Authors: A Buvé; H A Weiss; M Laga; E Van Dyck; R Musonda; L Zekeng; M Kahindo; S Anagonou; L Morison; N J Robinson; R J Hayes Journal: AIDS Date: 2001-08 Impact factor: 4.177
Authors: H L Martin; B A Richardson; P M Nyange; L Lavreys; S L Hillier; B Chohan; K Mandaliya; J O Ndinya-Achola; J Bwayo; J Kreiss Journal: J Infect Dis Date: 1999-12 Impact factor: 5.226
Authors: Harald Leitich; Barbara Bodner-Adler; Mathias Brunbauer; Alexandra Kaider; Christian Egarter; Peter Husslein Journal: Am J Obstet Gynecol Date: 2003-07 Impact factor: 8.661
Authors: Harald Leitich; Mathias Brunbauer; Barbara Bodner-Adler; Alexandra Kaider; Christian Egarter; Peter Husslein Journal: Am J Obstet Gynecol Date: 2003-03 Impact factor: 8.661
Authors: Heidi E Jones; Sheri A Lippman; Helio H Caiaffa-Filho; Taryn Young; Janneke H H M van de Wijgert Journal: J Clin Microbiol Date: 2013-01-16 Impact factor: 5.948
Authors: Neha S Shah; Evelyn Kim; Flor de Maria Hernández Ayala; Maria Elena Guardado Escobar; Ana Isabel Nieto; Andrea A Kim; Gabriela Paz-Bailey Journal: Int J STD AIDS Date: 2014-03-10 Impact factor: 1.359
Authors: Purnima Madhivanan; Karl Krupp; Jill Hardin; Chitra Karat; Jeffrey D Klausner; Arthur L Reingold Journal: Trop Med Int Health Date: 2009-04-20 Impact factor: 2.622
Authors: Jesse L Clark; Andres G Lescano; Kelika A Konda; Segundo R Leon; Franca R Jones; Jeffrey D Klausner; Thomas J Coates; Carlos F Caceres Journal: PLoS One Date: 2009-09-25 Impact factor: 3.240